Black Diamond Therapeutics I
-$15.2M
Net Activity
Institutions Holding
100
Popularity Rank
#4442
Avg Weight
0.01%
Total Value
$77.6M
Ownership Trend
100 institutions currently hold BDTX, with 49 net buyers and 55 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
55
Net Buying Institutions
49
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$33.2M
Total Buy Value
$51.4M
Total Sell Value
49
Net Buyers
55
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
1
Active 5%+ Holders
| Reporting Person | Type | Filing Date | % of Class |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 13G/A | 2026-07-08 | 7.0% |
Material Events (8-K)
No Form 8-K filings for this ticker
FAQ
Who are the top institutional investors holding BLACK DIAMOND THERAPEUTICS I (BDTX)?
What is the overall institutional sentiment toward BDTX recently?
Which institutions have been selling or reducing their BDTX positions?
Are there any notable investors adding BDTX to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
601
Total reported value
$20.1B
310 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
563
Total reported value
$25.2B
299 13F institutions increased their position this quarter
Vanguard Growth ETF
Institutions Holding
302
Total reported value
$4.3B
269 13F institutions increased their position this quarter